Medicinal properties in Ayurveda: ‘Charaka Samhita’ describes that "there is hardly any curable disease which cannot be controlled or cured with the application of Shilajit. Shilajit is described as an effective tonic for anemia and general debility. It regulates uterine contractions and promotes expulsion of the fetus. It is used like an antiseptic in parasitic diseases of the skin in the form of paste is locally applied to relieve rheumatic pain in joints and to strengthen muscles in the cases of paralysis. Shilajit is markedly effective in the treatment of various complications arising from diabetes. In Ayurveda it is indicated for use as alterative, anodyne, antiphlogistic, antiseptic, aphrodisiac, cholagogue, disinfectant, diuretic, expectorant, intestinal antiseptic, mildly laxative, parasiticide, rejuvenative, respiratory stimulant and as general tonic. Improves immunity and protects heart, brain and other vital organs of body.

Main classical uses: Shilajeet is widely used in Ayurvedic formulations. Shilajeet is recommended for direct use after diluting it with milk. Main classical Ayurvedic formulations containing Shilajeet as main ingredient are: Shilajatwadi vati, Arogyavardhini vati and Chandraprapha vati.

References:

• Dravyaguna Vigyan, By- Prof. Priyavrat Sharma, Published By- Chaukhambha Bharti Academy, Varanasi. INDIA.
• Bhavprakash Nighantu, By- Dr. Ganga Sahay Pandey & Dr. Krishna Chandra Chunekar.
  Published By- Chaukhamba Bharti Academy, Varanasi. INDIA.

Clinical studies / Clinical justification: Shilajeet is well supported with research papers published all over the world in renowned medical research journals of recent times also re-establish its use as an excellent rejuvenating tonic. Summary of some of the research papers is given below to support its inclusion in NEEROGA Capsules.

• 1) Shilajit: a review.

Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK.
Department of Pharmaceutics, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi 110062, India.

Shilajit is a pale-brown to blackish-brown exudation, of variable consistency, exuding from layers of rocks in many mountain ranges of the world, especially the Himalayas and Hindukush ranges of the Indian subcontinent. It has been found to consist of a complex mixture of organic humic substances and plant and microbial metabolites occurring in the rock rhizospheres of its natural habitat. Shilajit has been used as a rejuvenator and an adaptogen for thousands of years, in one form or another, as part of traditional systems of medicine in a number of countries. Many therapeutic properties have been ascribed to it, a number of which have been verified by modern scientific evaluation. Shilajit has been attributed with many miraculous healing properties.

---

• 2) J Ethnopharmacol. 1990 Apr;29(1):95-103.

Antiulcerogenic and antiinflammatory studies with shilajit.


Goel RK, Banerjee RS, Acharya SB.
Department of Pharmacology, Banaras Hindu University, Varanasi, India.

In folk medicine, shilajit has been used to treat diverse clinical conditions ranging from peptic ulcer to bone healing. The present study was conducted to evaluate the possible antiulcerogenic and antiinflammatory activities of shilajit obtained from the rocky mountains of Zarlek, Badekshan, Afghanistan. Shilajit increased the carbohydrate/protein ratio and decreased gastric ulcer index, indicating an increased mucus barrier. Shilajit was found to have significant antiinflammatory effect in carrageenan-induced acute pedal oedema, granuloma pouch and adjuvant-induced arthritis in rats. The results of the present study thus substantiate the use of shilajit in peptic ulcer and inflammation.

---

• 3) Indian J Exp Biol. 2000 Feb;38(2):119-28.

Adaptogenic activity of Siotone, a polyherbal formulation of Ayurvedic rasayanas.

Bhattacharya SK, Bhattacharya A, Chakrabarti A.
Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India.

Siotone (ST) is a herbal formulation comprising of Withania somnifera, Ocimum sanctum, Asparagus racemosus, Tribulus terristris and shilajit, all of which are classified in Ayurveda as rasayanas which are reputed to promote physical and mental health, improve defence mechanisms of the body and enhance longevity. These attributes are similar to the modern concept of adaptogenic agents, which are, known to afford protection of the human physiological system against diverse stressors. The present study was undertaken to investigate the adaptogenic activity of ST against chronic unpredictable, but mild, footshock stress induced perturbations in behaviour (depression), glucose metabolism, suppressed male sexual behaviour, immunosuppression and cognitive dysfunction in CF strain albino rats. Gastric ulceration, adrenal gland and spleen weights, ascorbic acid and corticosterone concentrations of adrenal cortex, and plasma corticosterone levels, were used as the stress indices. Panax ginseng (PG) was used as the standard adaptogenic agent for comparison. Additionally, rat brain levels of tribulin, an endogenous endocoid postulated to be involved in stress, were also assessed in terms of endogenous monoamine oxidase (MAO) A and MAOB inhibitory activity. Chronic unpredictable footshock induced marked gastric ulceration, significant increase in adrenal gland weight and plasma corticosterone levels, with concomitant decreases in spleen weight, and concentrations of adrenal gland ascorbic acid and corticosterone. These effects were attenuated by ST (50 and 100 mg/kg, p.o.) and PG (100 mg/kg, p.o.), administered once daily over a period of 14 days, the period of stress induction. Chronic stress also induced glucose intolerance, suppressed male sexual behaviour, induced behavioural depression (Porsolt's swim despair test and learned helplessness test) and cognitive dysfunction (attenuated retention of learning in active and passive avoidance tests), and immunosuppression (leucocyte migration inhibition and sheep RBC challenged increase in paw oedema in sensitized rats). All these chronic stress-induced perturbations were attenuated, dose-dependently by ST (50 and 100 mg/kg, p.o.) and PG (100 mg/kg, p.o.). Chronic stress-induced increase in rat brain tribulin activity was also reversed by these doses of ST and by PG. The results indicate that ST has significant adaptogenic activity, qualitatively comparable to PG, against a variety of behavioural, biochemical and physiological perturbations induced by unpredictable stress, which has been proposed to be a better indicator of clinical stress than acute stress parameters. The likely contribution of the individual constituents of ST in the observed adaptogenic action of the polyherbal formulation, have been discussed.

---

• 4) J Ethnopharmacol. 2006 Oct 11;107(3):349-53. Epub 2006 Apr 18.

The spermatogenic and ovogenic effects of chronically administered Shilajit to rats.
Park JS, Kim GY, Han K.
College of Pharmacy, Chungbuk National University, Cheongju, Heungdukgu Gaeshindong San 12, Chungbuk 361-763, South Korea.

This study examined the possibility of using Shilajit as a fertility agent. The effects of Shilajit on spermatogenesis and ovogenesis were studied using male and female rats. Shilajit was administered orally to 7-week-old rats over a 6-week period. In the male rats, the number of sperms in the testes and epididymides was significant higher than in the control. A histological examination revealed an apparent increase in the number of seminiferous tubular cell layers in the testes of the treated rats. However, there were no significant differences in the weights of heart, spleen, liver, kidney, brain, testes and epididymides. In the female rats, the effect of Shilajit was estimated by the ovulation inducing activity. Over a 5-day, ovulation was induced in seven out of nine rats in the Shilajit administration group and in three out of nine rats in the control. It was estimated that Shilajit had both a spermiogenic and ovogenic effect in mature rats.

---

• 5) Neurochem Int. 1997 Feb;30(2):181-90.

Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain.

Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V.
Paul Flechsig Institute for Brain Research, Department of Neurochemistry, University of Leipzig, Germany.

Although some promising results have been achieved by acetylcholinesterase inhibitors, an effective therapeutic intervention in Alzheimer's disease still remains an important goal. Sitoindosides VII-X, and withaferin-A, isolated from aqueous methanol extract from the roots of cultivated varieties of Withania somnifera (known as Indian Ginseng), as well as Shilajit, a pale-brown to blackish brown exudation from steep rocks of the Himalaya mountain, are used in Indian medicine to attenuate cerebral functional deficits, including amnesia, in geriatric patients. The present investigation was conducted to assess whether the memory-enhancing effects of plant extracts from Withania somnifera and Shilajit are owing to neurochemical alterations of specific transmitter systems. Therefore, histochemistry to analyse acetylcholinesterase activity as well as receptor autoradiography to detect cholinergic, glutamatergic and GABAergic receptor subtypes were performed in brain slices from adult male Wistar rats, injected intraperitoneally daily with an equimolar mixture of sitoindosides VII-X and withaferin-A (prepared from Withania somnifera) or with Shilajit, at doses of 40 mg/kg of body weight for 7 days. Administration of Shilajit led to reduced acetylcholinesterase staining, restricted to the basal forebrain nuclei including medial septum and the vertical limb of the diagonal band. Systemic application of the defined extract from Withania somnifera, however, led to differential effects on AChE activity in basal forebrain nuclei: slightly enhanced AChE activity was found in the lateral septum and globus pallidus, whereas in the vertical diagonal band AChE activity was reduced following treatment with sitoindosides VII-X and withaferin-A. These changes were accompanied by enhanced M1-muscarinic cholinergic receptor binding in lateral and medial septum as well as in frontal cortices, whereas the M2-muscarinic receptor binding sites were increased in a number of cortical regions including cingulate, frontal, piriform, parietal and retrosplenial cortex. Treatment with Shilajit or the defined extract from Withania somnifera affected neither GABAA and benzodiazepine receptor binding nor NMDA and AMPA glutamate receptor subtypes in any of the cortical or subcortical regions studied. The data suggest that Shilajit and the defined extract from Withania somnifera affect preferentially events in the cortical and basal forebrain cholinergic signal transduction cascade. The drug-induced increase in cortical muscarinic acetylcholine receptor capacity might partly explain the cognition-enhancing and memory-improving effects of extracts from Withania somnifera observed in animals and humans.